Lv11
10 积分 2026-03-14 加入
Lonafarnib in cancer therapy
7小时前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
6天前
已完结
[Advances in the treatment of anaplastic thyroid carcinoma]
24天前
已完结
Targeting the RAS upstream and downstream signaling pathway for cancer treatment
26天前
已完结
Targeting KRAS in cancer
26天前
已完结
Combinatorial strategies to target RAS-driven cancers
28天前
已完结
The current state of the art and future trends in RAS-targeted cancer therapies
28天前
已完结
Targeting Oncogenic RAS Protein
1个月前
已完结
The very druggable RAS proteins
1个月前
已完结
A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunities
1个月前
已完结
皖公网安备34019202002308
